✦ LIBER ✦

PIN35 COST-EFFECTIVENESS ANALYSIS OF PALIVIZUMAB FOR RESPIRATORY SYNCYTIAL VIRUS INFECTION IN HIGH-RISK INFANTS IN JAPAN

✍ Scribed by S Ikeda; M Kobayashi

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Palivizumab for respiratory syncytial vi

✍ Jennifer H. Lofland; Suzanne M. Touch; John P. O'Connor; Mary Lou Chatterton; El 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 890 KB

PIN72 Cost-Effectiveness Analysis of Pal

✍ M.Y. Lee; E.K. Lee 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

Cost-effectiveness analysis of palivizum

✍ Kristian Neovius; Katharina Buesch; Kristina Sandström; Martin Neovius 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 354 KB

Palivizumab, a Humanized Respiratory Syn

📂 Article 📅 1998 🏛 American Academy of Pediatrics 🌐 English ⚖ 340 KB

PIN24 COST-EFFECTIVENESS OF RESPIRATORY

✍ L.B. Weiner; M.J. Polak; A. Masaquel; P.J. Mahadevia 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

Impact of palivizumab on expected costs

✍ Albert Marchetti; Helen Lau; Raf Magar; Liping Wang; Giovanna Devercelli 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 993 KB